Your Search Returned 9 tagged news reports
Diabetic patients treated with three commonly prescribed sulfonylurea drugs had a 50% higher mortality risk compared with patients treated with metformin.
Tianyin Pharmaceutical's anti-diabetic drug Gliclazide Tablets (80mg formulation). Gliclazide is an oral sulfonylurea hypoglycemic agent which stimulates insulin secretion which stimulates beta cells of the islet of Langerhans in the pancreas to
Metformin is the recommended initial drug therapy for patients with type 2 diabetes mellitus (DM). However, the optimal second-line drug when metformin monotherapy fails is unclear. All noninsulin antidiabetic drugs were associated with similar HbA1c
The study used data accrued over nearly four years from the IMS LifeLink Health Plan Claims Database, comprised of medical and pharmaceutical claims for more than 65 million patients from 98 health plans across the US.
Monday, November 1, 2010 is a southern California Grocery Chain and also has pharmacies at some of their locations. According to the press release a patient needs to have a prescription from a doctor to get their diabetic medicine. In addition I
Gliclazide is commonly used to control mild to moderate adult-onset type 2 diabetes. Lotus Pharma's new controlled-release Gliclazide tablet is formulated using osmotic pump technology, which encases the drug in a semi-permeable framework for a
The safety of most diabetes drugs are time-tested insulin was discovered in the early 1920s, and two of the other most commonly prescribed, metformin and sulfonylurea, have been around since the 1950s...The drug landed with a splash on the market 11
Saleema Bibi, a newly diagnosed diabetic, asked incredulously and continued, "It's more like a lifelong imprisonment!" "Yes, my dear, the dose may vary but you, probably, are destined to take drugs for a long time to come," I replied and she should
Widely used diabetes drugs appear to increase patients' risk of potentially fatal heart problems, according to a study conducted by researchers from Imperial College London and published in the British Medical Journal . Researchers examined patient